FindTrial
Sign In

Determine patient demographic and clinical characteristics at baseline

OTHER2 trials

Sponsors

Hospices Civils de Lyon

Conditions

Adult Patients Developing Optic or Peripheral NeuropathyEfficacy and Safety of DalbavancinFor Acute or Chronic Infections Between July 2019 and December 2024In Subjects Who Received SAT with DALWhile Receiving Tedizolid Therapy Between July 2019 and December 2024

Unknown Phase

Efficacy and Safety of Dalbavancin As Suppressive Therapy
RecruitingNCT06899906
Hospices Civils de LyonEfficacy and Safety of Dalbavancin, For Acute or Chronic Infections Between July 2019 and December 2024, In Subjects Who Received SAT with DAL
Start: 2024-10-01End: 2025-05-01Target: 33Updated: 2025-03-28
Tedizolid Neuropathies
CompletedNCT07143240
Hospices Civils de LyonAdult Patients Developing Optic or Peripheral Neuropathy, While Receiving Tedizolid Therapy Between July 2019 and December 2024
Start: 2025-03-01End: 2025-05-01Updated: 2025-08-27